用途
sufficient for 250 colorimetric tests
种属反应性
rat, human, mouse
包装
pkg of 1 kit
储存条件
dry at room temperature
技术
activity assay: suitable
输入
plasma
urine
blood
serum
登记号
P69905
NM_000558.5
检测方法
colorimetric
相关疾病
hematological disorder
储存温度
2-8°C
基因信息
human ... HBA1(3039), HBA2(3040), HBB(3043)
mouse ... HBB(15129)
rat ... HBB(24440)
一般描述
血红蛋白（Hb）适应含铁金属蛋白质，是脊椎动物中氧气传递的主要方式。血红蛋白主要在红血细胞中它构成了细胞′s97%的干重。血红细胞还会存在在其他组织中，作为抗氧化剂。多种疾病，比如贫血和多细胞血症，会改变血液中血红细胞水平。
应用
血红细胞分析试剂盒可以用来检测血红细胞浓度。
适于检测血液、血清、血浆和尿液等多种样品中的血红蛋白成分。 本试剂盒可用于研究各类化合物对血红蛋白代谢和表达水平的调控作用。
生化/生理作用
该分析是根据改进Triton™[NP1]/NaOH方法，血红细胞被转化成比色产物，在400nm测量。该分析在96孔板分析中检测范围为 0.9-200 mg/dL。
特点和优势
兼容高通量的操作系统。 可在比色皿中使用。
法律信息
Triton is a trademark of The Dow Chemical Company or an affiliated company of Dow
警示用语：
Warning
危险声明
危险分类
Aquatic Acute 1 - Aquatic Chronic 2 - Eye Irrit. 2 - Met. Corr. 1
储存分类代码
8B - Non-combustible corrosive hazardous materials
Hemoglobin expression in nonerythroid cells: novel or ubiquitous?
Saha D, et al.
International Journal of Inflammation, 2014 (2014)
Viviana Lo Martire et al.
Frontiers in physiology, 9, 1818-1818 (2019-01-09)
Restless legs syndrome (RLS) is a neurological disorder that entails an urge to move with a circadian pattern during the evening/night. RLS may be accompanied by decreased sleep time and increased occurrence of periodic leg movements during sleep (PLMS), which
Cheng Chen et al.
Cell death & disease, 11(2), 135-135 (2020-02-23)
Diamond-Blackfan anemia (DBA) is a rare, inherited bone marrow failure syndrome, characterized by red blood cell aplasia, developmental abnormalities, and enhanced risk of malignancy. However, the underlying pathogenesis of DBA is yet to be understood. Recently, mutations in the gene
Malthe Hvas et al.
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 255, 110913-110913 (2021-02-02)
In this study, Atlantic salmon post smolts (~250 g, ~29 cm) were fasted for four weeks at 12 °C in full strength seawater. During this period, the critical swimming speed (Ucrit) was measured after 1, 2 and 4 weeks of fasting, as well as
Heechun Kwak et al.
Research and practice in thrombosis and haemostasis, 4(8), 1301-1312 (2020-12-15)
Replacement therapy is the most common treatment for reduction of bleeding and control of episodic bleeding in individuals with hemophilia. Despite the proven effectiveness of factor replacement therapy, repeated intravenous administration is a heavy burden to individuals with hemophilia. To
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持